Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
86.63
+4.54 (5.53%)
At close: Jun 25, 2026, 4:00 PM EDT
86.00
-0.63 (-0.73%)
Pre-market: Jun 26, 2026, 7:27 AM EDT
Oruka Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +38.52% | Jun 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $180 | Buy | Maintains | $180 | +107.78% | Jun 2, 2026 |
| UBS | UBS | Buy Reiterates $100 | Buy | Reiterates | $100 | +15.43% | Jun 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 2, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $125 | Buy | Maintains | $125 | +44.29% | May 23, 2026 |
| Wedbush | Wedbush | Buy Maintains $165 | Buy | Maintains | $165 | +90.47% | May 14, 2026 |
| BTIG | BTIG | Buy Maintains $151 | Buy | Maintains | $151 | +74.30% | May 14, 2026 |
| Barclays | Barclays | Buy Reiterates $160 | Buy | Reiterates | $160 | +84.69% | May 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.